Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001829126-26-001634
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.
- Iridex IRIX public float $14M, Jun 27, 2025
- Beyond Air XAIR public float $16M, Sep 30, 2025
- RetinalGenix Technologies RTGN public float $16M, Jun 30, 2025
- Harvard Apparatus Regenerative Technology HRGN public float $16M, Jun 30, 2025
- Biotricity BTCY public float $13M, Sep 30, 2025